E-TABM-1205 - Transcription profiling by array of mouse embryonic stem cells treated with valproic acid, cyproconazole and hexaconazole

Status
Released on 17 July 2012, last updated on 2 May 2014
Organism
Mus musculus
Samples (114)
Array (1)
Protocols (7)
Description
Effects of Valproic Acid, Cyproconazole and Hexaconazole on stem cell neural development.
Experiment types
transcription profiling by array, compound treatment
Contact
Citations
Complementary Detection of Embryotoxic Properties of Substances in the Neural and Cardiac Embryonic Stem Cell Tests. Peter T. Theunissen; Jeroen L. A. Pennings; Dorien A. M. van Dartel; Joshua F. Robinson; Jos C. S. Kleinjans; Aldert H. Piersma. Toxicol Sci 132(1):118 (2013), Europe PMC 23243006
Transcriptomic concentration-response evaluation of Valproic Acid, Cyproconazole and Hexaconazole in the neural embryonic stem cell test (ESTn). Theunissen PT, Robinson JF, Pennings JLA, de Jong E, Claessen SMH, Kleinjans JCS, Piersma AH. Toxicol Sci 125(2):430-8 (2012), Europe PMC 22045034
MIAME
PlatformsProtocolsFactorsProcessedRaw
Files
Investigation descriptionE-TABM-1205.idf.txt
Sample and data relationshipE-TABM-1205.sdrf.txt
Raw data (3)E-TABM-1205.raw.1.zip, E-TABM-1205.raw.2.zip, E-TABM-1205.raw.3.zip
Processed data (1)E-TABM-1205.processed.1.zip
Array designA-AFFY-45.adf.txt
R ExpressionSetE-TABM-1205.eSet.r
Links